支持单胎目标的当前证据:IVF与ICSI后双胎与单胎妊娠母婴结局综述
本文综述国际文献,比较体外受精与卵胞浆内单精子注射(IVF-ICSI)后双胎与单胎妊娠的母婴结局。综述确认双胎妊娠对母亲和围产儿健康的风险及医疗费用均显著更高,因此不孕症诊疗应持续降低双胎妊娠率至最低水平,以最大化治疗安全性。
要点
- IVF-ICSI后双胎妊娠的母婴健康风险显著高于单胎妊娠
- 双胎妊娠的医疗费用显著高于单胎妊娠
- 不孕症诊疗应持续努力将双胎妊娠率降至最低
核心结论
- IVF-ICSI后双胎妊娠对母婴健康的风险和医疗费用均显著高于单胎妊娠,应继续降低双胎妊娠率以最大化治疗安全性。
研究设计与样本
- 综述当前国际文献,比较IVF-ICSI治疗后双胎与单胎妊娠的母婴结局。
- 美国每年约2%的新生儿通过IVF-ICSI技术受孕。
- 美国IVF-ICSI后双胎妊娠率自2013年峰值以来有所下降,但仍约为每10至20次妊娠中1次。
主要发现
- 综述确认IVF-ICSI后双胎妊娠对母亲和围产儿健康的风险统计学显著更高。
- 双胎妊娠的医疗费用统计学显著更高。
临床怎么用
- 不孕症诊疗领域应继续发展实践措施,将双胎妊娠率降至绝对最低,以最大化这类医疗治疗的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With increasing use of in vitro fertilization and intracytoplasmic sperm injection (IVF-ICSI) almost 2% of all babies born in the United States each year are now conceived with these technologies, making outcomes of IVF-ICSI extremely important not only to patients and families but to public health. Twin pregnancy rates after IVF-ICSI in the United States have declined since their peak in 2013 but remain at approximately 1 in 10 to 1 in 20 pregnancies. A review of the current international literature on twin versus singleton pregnancy outcomes after IVF-ICSI treatment confirms statistically significantly higher risks to maternal and perinatal health and statistically significantly higher health care costs. The field of infertility care should continue to work to develop practices that lower twin pregnancy rates to an absolute minimum to maximize the safety of these medical treatments.
引用
- Eapen A, Ryan GL, Ten Eyck P, et al. Current evidence supporting a goal of singletons: a review of maternal and perinatal outcomes associated with twin versus singleton pregnancies after in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2020. PMID: 33040979. doi:10.1016/j.fertnstert.2020.08.1423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。